X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Biocon Ltd with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON LTD vs TEVA PHARMA (Israel) - Comparison Results

BIOCON LTD    Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 BIOCON LTD   TEVA PHARMA
EQUITY SHARE DATA
    BIOCON LTD
Mar-16
TEVA PHARMA
Dec-13
BIOCON LTD/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs4962,678-   
Low Rs3972,326-   
Sales per share (Unadj.) Rs174.31,537.0-  
Earnings per share (Unadj.) Rs44.896.0-  
Cash flow per share (Unadj.) Rs56.9220.2-  
Dividends per share (Unadj.) Rs5.0084.05-  
Dividend yield (eoy) %1.13.4 33.4%  
Book value per share (Unadj.) Rs202.81,707.3-  
Shares outstanding (eoy) m200.00848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.61.6 157.2%   
Avg P/E ratio x10.026.1 38.2%  
P/CF ratio (eoy) x7.811.4 69.0%  
Price / Book Value ratio x2.21.5 150.1%  
Dividend payout %11.287.5 12.7%   
Avg Mkt Cap Rs m89,2202,121,900 4.2%   
No. of employees `0004.444.9 9.8%   
Total wages/salary Rs m6,3630-   
Avg. sales/employee Rs Th7,894.528,998.7 27.2%   
Avg. wages/employee Rs Th1,441.20-   
Avg. net profit/employee Rs Th2,029.71,811.5 112.0%   
INCOME DATA
Net Sales Rs m34,8541,303,346 2.7%  
Other income Rs m8450-   
Total revenues Rs m35,6991,303,346 2.7%   
Gross profit Rs m8,200356,922 2.3%  
Depreciation Rs m2,423105,351 2.3%   
Interest Rs m10225,600 0.4%   
Profit before tax Rs m6,520225,972 2.9%   
Minority Interest Rs m-7441,027 -72.5%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m5,754-148,338 -3.9%   
Tax Rs m2,569-2,759 -93.1%   
Profit after tax Rs m8,96181,419 11.0%  
Gross profit margin %23.527.4 85.9%  
Effective tax rate %39.4-1.2 -3,227.3%   
Net profit margin %25.76.2 411.6%  
BALANCE SHEET DATA
Current assets Rs m39,932880,275 4.5%   
Current liabilities Rs m16,276767,674 2.1%   
Net working cap to sales %67.98.6 785.6%  
Current ratio x2.51.1 214.0%  
Inventory Days Days5491 59.0%  
Debtors Days Days8696 89.8%  
Net fixed assets Rs m39,101425,702 9.2%   
Share capital Rs m1,0003,208 31.2%   
"Free" reserves Rs m38,5910-   
Net worth Rs m40,5561,447,770 2.8%   
Long term debt Rs m20,724666,430 3.1%   
Total assets Rs m84,8162,978,564 2.8%  
Interest coverage x64.99.8 660.6%   
Debt to equity ratio x0.50.5 111.0%  
Sales to assets ratio x0.40.4 93.9%   
Return on assets %10.73.6 297.4%  
Return on equity %22.15.6 392.9%  
Return on capital %19.04.9 384.9%  
Exports to sales %30.70-   
Imports to sales %20.40-   
Net fx Rs m3,3960-   
CASH FLOW
From Operations Rs m5,264207,686 2.5%  
From Investments Rs m-9,540-73,592 13.0%  
From Financial Activity Rs m10,867-249,133 -4.4%  
Net Cashflow Rs m6,591-115,039 -5.7%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 64.16 Rs / USD

Compare BIOCON LTD With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare BIOCON LTD With: ABBOTT INDIA  FDC LTD.  CADILA HEALTHCARE  IPCA LABS  PANACEA BIOTECH  



Today's Market

Post Noon Sell-Off; Infosys Falls 5.4%(Closing)

Share markets in India witnessed a sharp fall in the final minutes of trade. At the closing bell, the BSE Sensex closed lower by 266 points. While, the NSE Nifty finished lower by 83 points.

Related Views On News

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Biocon: High Other Income And Licensing Income Drive Growth (Quarterly Results Update - Detailed)

Nov 7, 2016

Biocon has announced its 2QFY17. The company has reported 19.8% YoY growth in net sales and profits of Rs 1.5 bn for the quarter. Here is our analysis of the results.

Biocon: Lower R&D Expenses Help Margin Expansion (Quarterly Results Update - Detailed)

Sep 19, 2016

Biocon has announced its 1QFY17. The company has reported 21.1% YoY growth in total income and 34.6% YoY increase in net profits. Here is our analysis of the results.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON LTD SHARE PRICE


Aug 21, 2017 (Close)

TRACK BIOCON LTD

  • Track your investment in BIOCON LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE BIOCON LTD WITH

MARKET STATS